Interleukin 1 level, cognitive performance, and severity of depressive symptoms in patients treated with systemic anticancer therapy: a prospective study

AIM: To assess the relationship between cognitive functions, severity of depressive symptoms, and expression of interleukin 1 (IL)-1 in patients treated with systemic anticancer therapy. METHODS: This prospective study, conducted in 2017-2018, involved 55 patients (56% men) subjected to systemic ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Jasionowska, Justyna, Talarowska, Monika, Kalinka, Ewa, Skiba, Aleksandra, Szemraj, Janusz, Mikołajczyk, Iwona, Gałecki, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Croatian Medical Schools 2019
Materias:
Other Reseacrh
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509622/
https://www.ncbi.nlm.nih.gov/pubmed/31044590
http://dx.doi.org/10.3325/cmj.2019.60.166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509622/
https://www.ncbi.nlm.nih.gov/pubmed/31044590
http://dx.doi.org/10.3325/cmj.2019.60.166

Ejemplares similares